Skip to content

New nerve block to improve pain relief after hip replacement

Erector spinae block for total hip arthroplasty - a randomised trial to assess analgesic efficacy

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619000071123
Acronym
B-Hip Study
Enrollment
64
Registered
2019-01-18
Start date
2019-02-11
Completion date
2019-11-05
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

A recent audit of quality of recovery following hip replacement at Hollywood Hospital indicated that a proportion of patients experience significant pain in the 1st 24h following surgery. The aim of this study is to evaluate the efficacy a new nerve block termed the erector spinae block in reducing pain in the first 24h following hip replacement . A pilot audit of this nerve block technique in 33 patients at Hollywood found it to be safe and effective in reducing pain without any compromise to patient mobility.

Interventions

Ropivacaine 0.2% 30mls Delivered by anaesthetist via nerve block injection needle under ultrasound guidance to the transverse process of the 2nd lumbar vertebra - erector spine block

Sponsors

Dr Mark Lennon
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adults, aged > 18 years old, not pregnant 2. Elective unilateral total hip arthroplasty 3. Mentally competent to provide informed own written consent in English

Exclusion criteria

1. Eligible patients who are unable or unwilling to consent 2. Failure of spinal anaesthetic technique 3. Change in planned surgical technique due to for example femoral fracture requiring additional surgical procedures 4. Significant preoperative neuromuscular condition limiting mobility 5. Chronic opioid use > 40mg/d oral morphine equivalent 6. Revision surgery, bilateral surgery 7. Allergy or sensitivity to local anaesthetics

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026